65.45
-0.02(-0.03%)
Currency In USD
| Previous Close | 65.47 |
| Open | 66.22 |
| Day High | 68.07 |
| Day Low | 64.84 |
| 52-Week High | 90.32 |
| 52-Week Low | 41.5 |
| Volume | 2M |
| Average Volume | 1.79M |
| Market Cap | 3.48B |
| PE | -15.51 |
| EPS | -4.22 |
| Moving Average 50 Days | 65.13 |
| Moving Average 200 Days | 65.96 |
| Change | -0.02 |
If you invested $1000 in Soleno Therapeutics, Inc. (SLNO) 10 years ago, it would be worth $82.72 as of October 21, 2025 at a share price of $65.45. Whereas If you bought $1000 worth of Soleno Therapeutics, Inc. (SLNO) shares 5 years ago, it would be worth $466.67 as of October 21, 2025 at a share price of $65.45.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
GlobeNewswire Inc.
Oct 13, 2025 12:00 PM GMT
Appointment adds three decades of financial and operational leadership to Soleno’s BoardREDWOOD CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeu
Soleno Therapeutics to Participate in Upcoming September Conferences
GlobeNewswire Inc.
Aug 27, 2025 12:00 PM GMT
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in t
Soleno Therapeutics to Report Second Quarter 2025 Financial Results on August 6, 2025, at 4:30 PM ET
GlobeNewswire Inc.
Jul 28, 2025 12:00 PM GMT
REDWOOD CITY, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will report its secon